Skip to content

Girls twice as likely as boys to get HIV from their mothers in the womb

Premature and low birth weight babies becoming more frequent in HAART-treated mothers

Nevirapine for mums compromises their future treatment options

HAART clinically and immunologically effective in babies but high rate of virologic failure

Nevirapine should not be used for PEP confirms US review

Rapid HIV tests should be used on women in labour

AZT resistance and vertical transmission not seen since revised 1998 BHIVA guidelines

More evidence that earlier treatment provides greatest benefit for children with HIV

Daily nevirapine safe for breastfed infants